IRF2 and melanoma: Indeed, reporter assay data for rs3769823 in conjunction with E4F1 or IRF2 knockdown are consistent with this, where in melanoma cells knockdown of IRF2 resulted in a significant decrease of expression driven from the A-risk allele, while knockdown of E4F1 resulted in a weaker increase of reporter activity driven from the A-allele.